Clinical Neurology NewsTake precautions as cancer picture in MS remains hazyJune 11, 2018Multiple Sclerosis
Neurology ReviewsCladribine Tablets Improve MRI Outcomes in Patients With Highly Active Relapsing-Remitting MSJune 8, 2018Multiple Sclerosis
Neurology ReviewsCompared With Interferon, Fingolimod Improves MRI Outcomes of Pediatric MSJune 5, 2018Multiple Sclerosis
Neurology ReviewsCan Exercise Improve Vision in Children With MS?June 5, 2018Multiple SclerosisPediatrics
Neurology ReviewsMore Frequent Dosing of Interferon Beta-1a May Benefit Patients With MS With Breakthrough DiseaseJune 5, 2018Multiple Sclerosis
Neurology ReviewsOcrelizumab’s Benefits on Confirmed Disability Improvement Persist in Open-Label ExtensionJune 5, 2018Multiple Sclerosis
Clinical Neurology NewsGlobal MS trends: A chaotic picture with risk as the central themeJune 2, 2018Multiple Sclerosis
Clinical Neurology NewsFocus on preventing comorbidities in MS, physician urgesJune 2, 2018Multiple Sclerosis
Clinical Neurology NewsPregnancy may be ideal time to consider switching MS drugsJune 2, 2018Multiple Sclerosis
Clinical Neurology NewsMS clinic thrives by making regular care a ‘loss leader’June 2, 2018Multiple SclerosisBusiness of Medicine
Clinical Neurology NewsNew guidelines for gadolinium-based contrast agents take conservative stanceJune 1, 2018Multiple Sclerosis
Clinical Neurology NewsVIDEO: PML prevention is possible, even when treating patients with aggressive MSJune 1, 2018Multiple Sclerosis
Neurology ReviewsCan Neurologists Predict a Patient’s Nonadherence to DMTs for MS?June 1, 2018Multiple Sclerosis
